Company Filing History:
3 out of 987 
2 out of 41 
1 out of 2,488 
Years Active: 2009-2013
Title: Innovations of Garrett E Bergman
Introduction
Garrett E Bergman is a notable inventor based in Narberth, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of factor VIII deficiency. With a total of 3 patents to his name, his work has the potential to improve patient outcomes significantly.
Latest Patents
One of his latest patents is titled "Method of administering porcine B-domainless fVIII." This invention provides a method for administering porcine B-domainless factor VIII (OBI-1) to patients with factor VIII deficiency. The method aims to offer more rapid and effective protection against bleeding episodes compared to previously available methods. It is based on the discovery that recombinant B-domainless porcine fVIII, known as OBI-1, has greater bioavailability than the natural porcine fVIII partially purified from porcine plasma, referred to as HYATE:C. The inventive method allows for lower unit doses of OBI-1, which may include the omission of antibody-neutralizing dosage or longer intervals between administrations, providing equivalent protection for patients with fVIII deficiency. Additionally, the invention includes pharmaceutical compositions and kits containing OBI-1 combined with a pharmaceutically acceptable carrier, which are useful for treating patients in need of fVIII more effectively.
Career Highlights
Garrett E Bergman has worked with reputable organizations, including Emory University and Ipsen Biopharm Limited. His experience in these institutions has contributed to his expertise in the field of biomedical innovations.
Collaborations
He has collaborated with notable professionals, including John S Lollar, to advance his research and inventions.
Conclusion
Garrett E Bergman is a distinguished inventor whose work in the medical field has the potential to transform treatment options for patients with factor VIII deficiency. His innovative methods and collaborations highlight his commitment to improving healthcare outcomes.